| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Weakness in leg(s) | 4 | 1 | |
| Multiple sclerosis | 3 | 1 | |
| Amyotrophic lateral sclerosis | 2 | 1 | |
| Cognitive impairment | 2 | 1 | |
| Ankylosing spondylitis | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Excessive daytime sleepiness (somnolence) | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 6 |